Key facts
- eLux Medical’s last known valuation is $22.0M (Dec 2025).
- It has raised $10.3M across 2 recorded rounds; the latest was Seed Round ($1.3M) in Apr 2024.
- Notable investors include Plug and Play Tech Center, University of California, CONNECT (San Diego), EvoNexus, San Diego.
- eLux Medical has filed 2 Form Ds with the SEC since 2014, most recently Dec 2025 ($1.3M sold to 18 investors).
- Status: Acquired/Merged.
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for eLux Medical
Funding rounds
2 roundsAbout eLux Medical
Developer of a fat removal technology designed to disrupt the cosmetic surgery market. The company's technology offers a liposuction device that uses gold particles to remove twice the amount of fat in a procedure that takes half as long and without cosmetic effects, enabling patients with fat to get a slim look and decrease their weight.
- Sector
- Healthcare
- HQ
- Saint Thomas, VI
- Founded
- 2013
- Website
- eluxmedical.com/
- Ownership
- Acquired/Merged
eLux Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in eLux Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on eLux Medical in its N-PORT filings yet. We sweep new filings monthly.